1. Home
  2. MCB vs ELVN Comparison

MCB vs ELVN Comparison

Compare MCB & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Metropolitan Bank Holding Corp.

MCB

Metropolitan Bank Holding Corp.

HOLD

Current Price

$91.73

Market Cap

906.2M

Sector

Finance

ML Signal

HOLD

Logo Enliven Therapeutics Inc.

ELVN

Enliven Therapeutics Inc.

HOLD

Current Price

$25.49

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MCB
ELVN
Founded
1999
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
906.2M
1.1B
IPO Year
2017
2020

Fundamental Metrics

Financial Performance
Metric
MCB
ELVN
Price
$91.73
$25.49
Analyst Decision
Buy
Strong Buy
Analyst Count
2
4
Target Price
$97.50
$41.00
AVG Volume (30 Days)
185.2K
1.6M
Earning Date
01-20-2026
03-12-2026
Dividend Yield
0.87%
N/A
EPS Growth
11.64
N/A
EPS
6.62
N/A
Revenue
$277,514,000.00
N/A
Revenue This Year
$29.07
N/A
Revenue Next Year
$7.96
N/A
P/E Ratio
$13.90
N/A
Revenue Growth
2.53
N/A
52 Week Low
$47.08
$13.30
52 Week High
$96.75
$29.98

Technical Indicators

Market Signals
Indicator
MCB
ELVN
Relative Strength Index (RSI) 65.29 61.29
Support Level $87.74 $24.90
Resistance Level $96.75 $28.69
Average True Range (ATR) 3.62 1.57
MACD 0.70 -0.07
Stochastic Oscillator 74.08 41.15

Price Performance

Historical Comparison
MCB
ELVN

About MCB Metropolitan Bank Holding Corp.

Metropolitan Bank Holding Corp is a bank holding company. It provides a broad range of business, commercial, and retail banking products and services to small businesses, middle-market enterprises, public entities, and individuals in the New York metropolitan area. The services provided by the company include deposits, trade finance, cash management solutions, savings, electronic banking, cards, and others. The company also provides various lending products such as acquisition loans, construction loans, and lines of credit, for retail, office, hospitality, multifamily, mixed-use, warehouse and distribution, and specialty-use properties. The bank derives its revenue in the form of interest income on loans.

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.

Share on Social Networks: